Loading…

UPLUPL.NSCompetitor analysis, valuation and peers

India · INR·Chemicals›Chemicals: Agricultural

One of the world's largest generic crop-protection (pesticide/herbicide) and seed companies, based in India.

Momentum neutral 45
Mkt cap
$4.78B
US dollars, full cap
Free float
66%
of shares outstanding
$/day
$13.0M
20-day average traded
Fwd P/E
14.8×
forward earnings
ROIC−WACC
-5.1 pp
WACC 12.2%
Hurdle
+5 pp
Req g minus delivered
Official | Implied
BB / B
agencies · bond market
Next earnings
100 days
14 Feb 2027
Close · INR₹534.90
1D+1.6%
1W+4.2%
1M+8.1%
3M-6.6%
6M-17.8%
YTD-32.7%
1Y-25.9%
ATR %3.5%
Beta1.17
52w lowhigh34.1% off high

What UPL does

One of the world's largest generic crop-protection (pesticide/herbicide) and seed companies, based in India.

Sells off-patent crop-protection chemicals through distributors and retailers to farmers, so volumes follow planting seasons and weather, and prices follow generic competitors from China. The 2019 purchase of Arysta made it a global player, especially in Latin America, and left debt it has worked to reduce. Seeds, through its Advanta unit, are a separate business.

Products and services

  • Herbicides
  • Insecticides/fungicides
  • Seeds
  • Specialty/post-patent generics

Customers

  • Farmers globally (via distributors)
  • Agricultural input retailers

Where it sits in the supply chain

  • Agrochemicals
  • Crop protection (pesticides…
  • Seeds & post-patent agrochemical…

What could go right

  • Global farm input demand growth
  • Debt reduction/deleveraging

What could go wrong

  • High leverage from Arysta acquisition
  • Crop-price/farm-income cyclicality

Moat: narrow (scale, distribution, regulatory licence). Global generic-agrochemical scale and distribution built via the Arysta acquisition, but faces intense competition from bigger patent-holding majors.

Headquarters: Mumbai, India · Founded: 1969 · Employees: 12,399

Named competitors

UPL at a glance

Size UPL (UPL.NS) is an India Materials company (Chemicals: Agricultural) with a market value of $4.78B, the 216th largest of 1,058 India companies the cockpit tracks. Shares closed at ₹534.90 on 6 Nov 2026.

Performance Over six months the shares fell 17.8%, against -25.6% for the median peer and 0.0% for the India market (cap-weighted) — 6th highest of 21 in its peer set.

Growth Revenue grew 10.3% over the last twelve months (peer median +4.9%); the operating margin is 13.7% (peer median 10.7%).

Valuation It trades at 14.8× forward earnings against a peer median of 17.9× (7th cheapest of 19).

Price implies For today's price to make sense, revenue must grow about 11% a year for seven years (Req g). Recent delivered growth is +6%, so the hurdle is +5 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 5.1 points below its cost of capital (12.2% WACC).

Credit UPL has 2 bonds outstanding ($800M), rated BB by the agencies and trading like B at a weighted spread of 327 bp.

Next results Next results expected around 14 Feb 2027 (exchange calendar; dates can move).

Relative performance

70809010011 May 202611 Aug 20266 Nov 2026UPL.NS 83Peer median 75
Six months, rebased to 100: UPL against the median of its 20 peers (local-currency closes).

UPL financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₹526B₹515B₹465B₹428B₹534B
Revenue growth—+11%+9%-20%—
Gross profit₹178B₹127B₹117B₹79.9B₹157B
EBITDA₹106B₹90.7B₹79.8B₹52.4B₹111B
Net income₹18.9B₹18.5B₹7.59B-₹13.4B₹34.4B
Free cash flown/a₹41.0B₹63.3B-₹23.9B₹39.5B
Capital expendituren/a₹24.1B₹16.9B₹19.9B₹23.6B
Total debt₹342B₹234B₹279B₹325B₹268B

Quarterly statements and history in the cockpit →

UPL competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%-20%-10%0%+10%DNLFACTICLSMG600486MOS000902603077000155301035002539YAR002312002258600596SUMICHEMATUL000422BAYERCROPUPL.NS6-month return →1-month return →
Up and to the right = strong over both horizons. UPL is the large dot.

Fundamentals: revenue growth against valuation

0%+50%+100%25×50×75×DNLICLSMGMOS000902000155301035YAR002312002258TATACHEM000422UPL.NSRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. UPL is the large dot.

Capital: growth delivered against growth the price implies

0%+10%+20%0%10%20%ICLSMG600486301035YAR002312600596SUMICHEMATULBAYERCROPUPL.NSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. UPL is the large dot.

UPL competitors and peer comparison

Head to head with its named competitors (UPL.NS vs BAYN.DE vs CTVA vs PIIND.NS)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
UPL UPL.NS$4.78B-18%+10%14%14.8×10.9%
Bayer BAYN.DE$61.2B+46%-2%14%12.3×2.1%
Corteva CTVA$7.94B-85%+4%17%30.4×-16.6%
PI Industries PIIND.NS$2.79B-44%-15%13%22.7×n/a

How UPL compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

UPL against its 20 peers (data as of 6 Nov 2026)
MeasureUPL.NSPeer medianRank in peer set
1-month return+8.1%-5.2%6th highest of 21
6-month return-17.8%-25.6%6th highest of 21
Distance from 52-week high-34.1%-33.1%10th lowest of 21
Revenue growth (TTM)+10.3%+4.9%7th highest of 21
Operating margin13.7%10.7%6th highest of 21
Forward P/E14.8×17.9×7th cheapest of 19
Growth the price implies (Req g, 7 yrs)10.9%7.9%5th most demanding of 11
Growth delivered (Del g)+6.0%+6.6%6th highest of 11
Hurdle (Req g minus delivered)+5.0 pp+2.1 pp6th least demanding of 11
ROIC minus cost of capital-5.1 pp+0.6 pp5th lowest of 21
EV / EBITDA7.7×9.7×4th cheapest of 10
Net debt / EBITDA2.9×1.8×5th most indebted of 11
Bond spread327 bp118 bpwidest of 5

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
UPL UPL.NSIndia$4.78B-18%+10%14%14.8×10.9%+6.0%
Dyno Nobel DNL.AXAustralia$4.64B+6%-17%15%21.1×n/an/a
Fertilizers & Chemicals Travancore FACT.NSIndia$5.14B-18%+32%0%n/an/an/a
ICL ICLUnited States$6.04B-27%+11%11%11.5×3.5%+7.2%
Scotts Miracle-Gro SMGUnited States$3.77B+6%-4%14%13.6×7.5%-7.8%
Jiangsu Yangnong Chemical 600486.SSChina$3.42B-22%+3%13%16.2×0.8%+3.8%
Mosaic Company (The) MOSUnited States$7.11B+2%0%3%26.2×n/an/a
YONFER Agricultural Technology 000902.SZChina$2.69B-2%+15%11%11.4×n/an/a
Sichuan Hebang Biotechnology 603077.SSChina$2.59B-30%-24%-1%n/an/an/a
Sichuan New Energy Power 000155.SZChina$2.54B-47%+98%32%12.9×n/an/a
Shandong Weifang Rainbow Chemical 301035.SZChina$2.42B-32%+6%12%14.9×-0.1%+15.0%
Chengdu Wintrue 002539.SZChina$2.09B-24%+6%6%11.7×n/an/a
Yara International YAR.OLNorway$11.0B-26%+2%13%8.2×-6.9%+8.3%
Sichuan Development Lomon 002312.SZChina$1.93B-36%+5%6%35.0×8.2%+14.0%
Lier Chemical 002258.SZChina$1.85B+20%+6%8%21.0×n/an/a
Zhejiang Xinan Chemical Industrial 600596.SSChina$1.75B-31%+5%2%22.9×12.4%+3.1%
Sumitomo Chemical India SUMICHEM.NSIndia$1.74B-34%-3%18%28.1×23.4%+4.1%
Tata Chemicals TATACHEM.NSIndia$1.64B-25%+2%3%85.9×n/an/a
Atul ATUL.NSIndia$1.63B-26%+18%12%19.7×18.2%+11.0%
Hubei Yihua Chemical Industry 000422.SZChina$1.60B-42%+15%5%15.2×n/an/a
Bayer Cropscience India BAYERCROP.NSIndia$1.58B-28%-5%15%19.5×16.1%+5.9%

UPL bonds and credit

UPL has 2 bonds outstanding with $800M face value. The agencies rate it BB; its bonds trade like B. Weighted yield 7.79%, a spread of 327 bp over government bonds.

Every bond, yield and spread in the cockpit →

Questions

Who are UPL's main competitors?
Named competitors: Bayer Crop Science (BAYN.DE), Syngenta (private or unlisted), Corteva (CTVA), PI Industries (PIIND.NS). The cockpit's measured peer set (industry) also includes Dyno Nobel (DNL.AX), Fertilizers & Chemicals Travancore (FACT.NS), ICL (ICL), Scotts Miracle-Gro (SMG), Jiangsu Yangnong Chemical (600486.SS), Mosaic Company (The) (MOS).
Is UPL expensive compared with its peers?
On forward p/e it trades at 14.8× against a peer median of 17.9×, 7th cheapest of 19 in its peer set. For today's price to make sense, revenue must grow about 11% a year for seven years (Req g). Recent delivered growth is +6%, so the hurdle is +5 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has UPL stock performed?
Over six months to 6 Nov 2026 the shares returned -17.8% against -25.6% for the median peer; over one year -25.9%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.